Post-IPO Equity Medical Companies

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

PAVmed is a groundbreaking medical device company bringing innovative medical technology.

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Greenbrook provides Transcranial Magnetic Stimulation (TMS) therapy for individuals with treatment-resistant depression.

Kanabo is creating a new standard in the medical cannabis industry by building an ecosystem.

Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

OrganiGram is a producer and distributor of medical and recreational cannabis.

Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Catheter Robotics is a medical device development and manufacturing company.

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.